Literature DB >> 25798670

Very late-onset reversible cardiomyopathy in patients with chronic GvHD.

H Kawano1, H Tanaka2, T Yamashita2, K-I Hirata2, S Ishii1, T Suzuki1, K Wakahashi1, Y Kawano1, A Sada1, K Minagawa1, F Kawakami3, T Itoh3, A Baba4, T Matsui5, Y Katayama1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25798670     DOI： 10.1038/bmt.2015.40

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  12 in total

1.  Complete elimination of cardiodepressant IgG3 autoantibodies by immunoadsorption in patients with severe heart failure.

Authors:  Akiyasu Baba; Makoto Akaishi; Megumi Shimada; Toshiaki Monkawa; Yasuhisa Wakabayashi; Michiko Takahashi; Yuji Nagatomo; Tsutomu Yoshikawa
Journal:  Circ J       Date:  2010-05-22       Impact factor: 2.993

2.  Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity.

Authors:  Michael S Ewer; Scott M Lippman
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

3.  Chronic GVHD and concurrent new-onset nephrotic syndrome in allogeneic transplant recipients. Incidence, pattern and therapeutic outcomes.

Authors:  B Dhakal; A Singavi; E P Cohen; M Dangal; J Palmer; A Dall; A D'Souza; M Hamadani; P N Hari
Journal:  Bone Marrow Transplant       Date:  2014-11-10       Impact factor: 5.483

4.  Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy.

Authors:  Alexander Staudt; Marko Böhm; Fabian Knebel; Yvonne Grosse; Claudia Bischoff; Astrid Hummel; Johannes B Dahm; Adrian Borges; Nicoline Jochmann; Klaus D Wernecke; Gerd Wallukat; Gert Baumann; Stephan B Felix
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

Review 5.  Cytokine-induced modulation of cardiac function.

Authors:  Sumanth D Prabhu
Journal:  Circ Res       Date:  2004-12-10       Impact factor: 17.367

6.  Cardiac manifestations of graft-versus-host disease.

Authors:  Cynthia Rackley; Kirk R Schultz; Frederick D Goldman; Ka Wah Chan; Amy Serrano; James E Hulse; Andrew L Gilman
Journal:  Biol Blood Marrow Transplant       Date:  2005-10       Impact factor: 5.742

7.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

8.  Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997.

Authors:  T Murdych; D J Weisdorf
Journal:  Bone Marrow Transplant       Date:  2001-08       Impact factor: 5.483

9.  Autoantigen estimation and simple screening assay against cardiodepressant autoantibodies in patients with dilated cardiomyopathy.

Authors:  Akiyasu Baba
Journal:  Ther Apher Dial       Date:  2008-04       Impact factor: 1.762

Review 10.  Advances in graft-versus-host disease biology and therapy.

Authors:  Bruce R Blazar; William J Murphy; Mehrdad Abedi
Journal:  Nat Rev Immunol       Date:  2012-05-11       Impact factor: 53.106
View more
  1 in total

1.  High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation.

Authors:  Koichi Miyamura; Takuya Yamashita; Yoshiko Atsuta; Tatsuo Ichinohe; Koji Kato; Naoyuki Uchida; Takahiro Fukuda; Kazuteru Ohashi; Hiroyasu Ogawa; Tetsuya Eto; Masami Inoue; Satoshi Takahashi; Takehiko Mori; Heiwa Kanamori; Hiromasa Yabe; Asahito Hama; Shinichiro Okamoto; Yoshihiro Inamoto
Journal:  Blood Adv       Date:  2019-02-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.